High Blood Pressure
Research Study

Researchers at Massachusetts General Hospital are conducting a research study called CARDAMOM to investigate whether the medication eplerenone can help reduce future cardiovascular risks in women who have a history of pregnancy-induced high blood pressure and currently have chronic high blood pressure. The study will examine the effects of different blood pressure medications on heart health over 60 weeks.

Fast Facts

Women ages 18–65

Diagnosed with high blood pressure during pregnancy & still have high blood pressure

Compensation
up to $1,900

Conducted in
Boston, MA

Additional Information

This study is being done to determine whether eplerenone can help reduce future cardiovascular risks in women who previously experienced high blood pressure during pregnancy and now have chronic high blood pressure. Researchers hope to better understand how different blood pressure medications affect long-term heart health.

You may be eligible for this study if you meet the following criteria.

  • Women who had high blood pressure during pregnancy
  • Currently have high blood pressure
  • Not currently pregnant
  • Do not use oral contraceptives or menopausal hormone therapy
  • Not taking allopurinol or lithium
  • Do not have type 2 diabetes
  • If taking a GLP-1 medication, have been on a stable dose for 12 months

Participation in this 60-week study involves seven in-person visits at Massachusetts General Hospital. Study activities include bloodwork, physical exams, heart imaging, and blood pressure monitoring.

If you qualify and decide to participate, the study will involve the following steps:

  1. Screening Visit: Complete bloodwork, a physical exam, an EKG, and a cardiac ultrasound to determine eligibility.

  2. Initial Medication Period: If eligible, take amlodipine for three months to assess medication tolerance and help maintain healthy blood pressure.

  3. Second Study Visit: Return to Mass General for bloodwork, an echocardiogram, a cardiac PET scan, and an eye exam and imaging.

  4. Study Treatment: You will be randomly assigned to receive either eplerenone or chlorthalidone, both FDA-approved blood pressure medications.

  5. Follow-Up Visits: Continue taking your assigned medication for 48 weeks while attending four additional visits for bloodwork and monitoring.

  6. Final Study Visit: Complete final bloodwork and heart imaging to evaluate the effects of the study treatment.

Throughout the study, you will also be asked to measure your blood pressure at home every day.

You can receive $1,900 for completing the entire study. Additional perks for participating include:

  • Parking validation at Mass General Hospital parking lots.

  • Access to bloodwork results from screening and post-treatment visits.

  • A final echocardiogram reading from your post-treatment visit.

There is no cost for you to participate in our research study.